Table 2.
Ref. |
Disease-free survival |
Overall survival |
||||||
1 yr | 2 yr | 3 yr | 5 yr | 1 yr | 2 yr | 3 yr | 5 yr | |
Gigot et al[59] | 43.70% | 62.50% | ||||||
Chen et al[53] | 85.4%-94.7% | 66.4%-74.2% | 59.4%-61.7% | |||||
Tranchart et al[36] | 60.90% | 45.60% | 74.40% | 59.50% | ||||
Yoon et al[8] | 60.40% | 90.40% | ||||||
Lai et al[30] | 85% | 47% | 38% | 96% | 67% | 52% | ||
Belli et al[31] | 81% | 62% | 32% | 95% | 70% | 55% | ||
Truant et al[32] | 35.50% | 70% | ||||||
Lee et al[33] | 78.80% | 51% | 45.30% | 86.90% | 81.80% | 76% | ||
Hu et al[34] | 50% | |||||||
Yoon et al[25] | 52.90% | 46.40% | 93.30% | 85.90% | ||||
Choi et al[23] | 71% | 81% | ||||||
Inagaki et al[45] | 79.30% |